Oncogenic viruses and tumor glucose metabolism: Like kids in a candy store

Molecular Cancer Therapeutics

Volumn 11, Issue 1, 2012, Pages 14-23

  Noch, Evan ^a   Khalili, Kamel ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; HEXOKINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PENTOSE PHOSPHATE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN P53; PYRUVATE KINASE;

CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CELL STRESS; CELL TRANSFORMATION; CELLULAR STRESS SIGNAL; DNA DAMAGE; ENERGY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; METABOLOMICS; NONHUMAN; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR VIRUS;

CELL CYCLE; CELL PROLIFERATION; GLUCOSE; GLYCOLYSIS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NEOPLASMS; ONCOGENIC VIRUSES; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 84855699824     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-11-0517     Document Type: Review

References (82)

1. Saha A, Murakami M, Kumar P, Bajaj B, Sims K, Robertson ES. Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2. J Virol 2009;83:4652-69.
2. Krynska B, Del Valle L, Gordon J, Otte J, Croul S, Khalili K. Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma. Virology 2000;274:65-74. (Pubitemid 30650683)
3. Giampieri S, García-Escudero R, Green J, Storey A. Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation. Oncogene 2004;23:5864-70. (Pubitemid 39093033)
4. O'Shaughnessy RF, Akgul B, Storey A, Pfister H, Harwood CA, Byrne C. Cutaneous human papillomaviruses down-regulate AKT1, whereas AKT2 up-regulation and activation associates with tumors. Cancer Res 2007;67:8207-15. (Pubitemid 47395157)
5. Rösl F, Das BC, Lengert M, Geletneky K, zur Hausen H. Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J Virol 1997;71:362-70. (Pubitemid 26412300)
6. Yodoi J,Tursz T. ADF, a growth-promotingfactor derived fromadult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBV. Adv Cancer Res 1991;57:381-411.
7. Waris G, Siddiqui A. Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 inRNA replication. J Virol 2005;79:9725-34. (Pubitemid 41022315)
8. El Mjiyad N, Caro-Maldonado A, Ramírez-Peinado S, Muñoz-Pinedo C. Sugar-free approaches to cancer cell killing. Oncogene 2011;30:253-64.
9. Mizrachy-Schwartz S, Kravchenko-Balasha N, Ben-Bassat H, Klein S, Levitzki A. Optimization of energy-consuming pathways towards rapid growth in HPV-transformed cells. PLoS ONE 2007;2:e628.
10. Rezvani HR, KimAL, Rossignol R, Ali N, Daly M, Mahfouf W, et al. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest 2011;121:195-211.
11. Fukuda M, Longnecker R. Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway. J Virol 2007;81:9299-306. (Pubitemid 47311472)
12. Menges CW, Baglia LA, Lapoint R, McCance DJ. Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res 2006;66:5555-9. (Pubitemid 43927104)
13. Yuan H, Veldman T, Rundell K, Schlegel R. Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells. J Virol 2002;76:10685-91. (Pubitemid 35176184)
14. Sabbatini P, McCormick F. Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis. J Biol Chem 1999;274:24263-9.
15. Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 2004;64:3892-9. (Pubitemid 38697301)
16. Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW, Young LS. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem 1999;274:16085-96.
17. Chakrabarti O, Veeraraghavalu K, Tergaonkar V, Liu Y, Androphy EJ, Stanley MA, et al. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol 2004;78:5934-45. (Pubitemid 38661681)
18. Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, et al. MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. J Biol Chem 2001;276:19800-6.
19. Martinez-Outschoorn UE, Whitaker-Menezes D, Pavlides S, Chiavarina B, Bonuccelli G, Casey T, et al. The autophagic tumor stroma model of cancer or "battery-operated tumor growth": a simple solution to the autophagy paradox. Cell Cycle 2010;9:4297-306.
20. Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, et al. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 2011;10:1772-83.
21. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004;64:2627-33. (Pubitemid 38523921)
22. Khutornenko AA, Roudko VV, Chernyak BV, Vartapetian AB, Chumakov PM, Evstafieva AG. Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway. Proc Natl Acad Sci USA 2010;107:12828-33.
23. Doherty J, Freund R. Polyomavirus large T antigen overcomes p53 dependent growth arrest. Oncogene 1997;14:1923-31. (Pubitemid 27217805)
24. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, et al. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 1993;90:3988-92. (Pubitemid 23134151)
25. Parker GA, Crook T, Bain M, Sara EA, Farrell PJ, Allday MJ. Epstein- Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 1996;13:2541-9. (Pubitemid 27046110)
26. Tanaka T, Kurose A, Halicka HD, Traganos F, Darzynkiewicz Z. 2-Deoxy-D-glucose reduces the level of constitutive activation of ATM and phosphorylation of histone H2AX. Cell Cycle 2006;5:878-82. (Pubitemid 44145584)
27. Gruhne B, Sompallae R, Masucci MG. Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene 2009;28:3997-4008.
28. Ousset M, Bouquet F, Fallone F, Biard D, Dray C, Valet P, et al. Loss of ATM positively regulates the expression of hypoxia inducible factor 1 (HIF-1) through oxidative stress: role in the physiopathology of the disease. Cell Cycle 2010;9:2814-22.
29. Sun Y, Connors KE, Yang DQ. AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner. Mol Cell Biochem 2007;306:239-45. (Pubitemid 350001836)
30. Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 2008;8:705-13.
31. Wakisaka N, Kondo S, Yoshizaki T, Murono S, Furukawa M, Pagano JS. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol Cell Biol 2004;24:5223-34. (Pubitemid 38738158)
32. Nakamura M, Bodily JM, Beglin M, Kyo S, Inoue M, Laimins LA. Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses. Virology 2009;387:442-8.
33. BirnbaumMJ, Haspel HC, Rosen OM. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science 1987;235:1495-8. (Pubitemid 17038085)
34. Kitagawa K, Nishino H, Iwashima A. Analysis of hexose transport in untransformed and sarcoma virus-transformed mouse 3T3 cells by photoaffinity binding of cytochalasin B. Biochim Biophys Acta 1985;821:63-6. (Pubitemid 16233565)
35. Bissell MJ. Transport as a rate limiting step in glucose metabolism in virus-transformed cells: studies with cytochalasin B. J Cell Physiol 1976;89:701-9.
36. Weber MJ. Hexose transport in normal and in Rous sarcoma virus-transformed cells. J Biol Chem 1973;248:2978-83.
37. Leiprecht N, Munoz C, Alesutan I, Siraskar G, Sopjani M, Föller M, et al. Regulation of Na(+)-coupled glucose carrier SGLT1 by human papillomavirus 18 E6 protein. Biochem Biophys Res Commun 2011;404:695-700.
38. Hatanaka M, Huebner RJ, Gilden RV. Alterations in the characteristics of sugar uptake by mouse cells transformed by murine sarcoma viruses. J Natl Cancer Inst 1969;43:1091-6.
39. Young AT, Dahl J, Hausdorff SF, Bauer PH, Birnbaum MJ, Benjamin TL. Phosphatidylinositol 3-kinase binding to polyoma virus middle tumor antigen mediates elevation of glucose transport by increasing translocation of the GLUT1 transporter. Proc Natl Acad Sci USA 1995;92:11613-7. (Pubitemid 26014163)
40. Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 2003;115:449-59. (Pubitemid 37456807)
41. Akaoka H, Szymocha R, Beurton-Marduel P, Bernard A, Belin MF, Giraudon P. Functional changes in astrocytes by human T-lymphotropic virus type-1 T-lymphocytes. Virus Res 2001;78:57-66. (Pubitemid 32772823)
42. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
43. Mazurek S, Boschek CB, Hugo F, Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 2005;15:300-8. (Pubitemid 41058775)
44. Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Dürr P. Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc Natl Acad Sci USA 1999;96:1291-6. (Pubitemid 29098444)
45. Mazurek S, Michel A, Eigenbrodt E. Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates. J Biol Chem 1997;272:4941-52. (Pubitemid 27090044)
46. Mazurek S, Zwerschke W, Jansen-Dürr P, Eigenbrodt E. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolyticenzyme complex. Biochem J 2001;356:247-56. (Pubitemid 34275727)
47. Eigenbrodt E, Kallinowski F, Ott M, Mazurek S, Vaupel P. Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors. Anticancer Res 1998;18:3267-74. (Pubitemid 28546445)
48. Presek P, Glossmann H, Eigenbrodt E, Schoner W, Rübsamen H, Friis RR, et al. Similarities between a phosphoprotein (pp60src)- associated protein kinase of Rous sarcoma virus and a cyclic adenosine 3¢:5¢- monophosphate-independent protein kinase that phosphorylates pyruvate kinase type M2. Cancer Res 1980;40:1733-41. (Pubitemid 10102025)
49. Presek P, Reinacher M, Eigenbrodt E. Pyruvate kinase type M2 is phosphorylated at tyrosine residues in cells transformed by Rous sarcoma virus. FEBS Lett 1988;242:194-8. (Pubitemid 19012276)
50. Pierce GN, Philipson KD. Binding of glycolytic enzymes to cardiac sarcolemmal and sarcoplasmic reticular membranes. J Biol Chem 1985;260:6862-70. (Pubitemid 15010616)
51. Cooper JA, Reiss NA, Schwartz RJ, Hunter T. Three glycolytic enzymes are phosphorylated at tyrosine in cells transformed by Rous sarcoma virus. Nature 1983;302:218-23. (Pubitemid 13109188)
52. Singh M, Singh VN, August JT, Horecker BL. Alterations in glucose metabolism in chick embryo cells transformed by Rous sarcoma virus. Transformation-specific changes in the activities of key enzymes of the glycolytic and hexose monophosphate shunt pathways. Arch Biochem Biophys 1974;165:240-6.
53. Bissell MJ, White RC, Hatie C, Bassham JA. Dynamics of metabolism of normal and virus-transformed chick cells in culture. Proc Natl Acad Sci USA 1973;70:2951-5.
54. Bosca L, Mojena M, Ghysdael J, Rousseau GG, Hue L. Expression of the v-src or v-fps oncogene increases fructose 2,6-bisphosphate in chick-embryo fibroblasts. Novel mechanism for the stimulation of glycolysis by retroviruses. Biochem J 1986;236:595-9. (Pubitemid 16037010)
55. Marchand MJ, Maisin L, Hue L, Rousseau GG. Activation of 6-phosphofructo-2-kinase by pp60v-src is an indirect effect. Biochem J 1992;285:413-7.
56. Singh VN, Singh M, August JT, Horecker BL. Alterations in glucose metabolism in chick-embryo cells transformed by Rous sarcoma virus: intracellular levels of glycolytic intermediates. Proc Natl Acad Sci USA 1974;71:4129-32.
57. Delgado T, Carroll PA, Punjabi AS, Margineantu D, Hockenbery DM, Lagunoff M. Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc Natl Acad Sci USA 2010;107:10696-701.
58. Carroll PA, Kenerson HL, Yeung RS, Lagunoff M. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors. J Virol 2006;80:10802-12. (Pubitemid 44628926)
59. Maehama T, Patzelt A, Lengert M, Hutter KJ, Kanazawa K, Hausen H, et al. Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose. Int J Cancer 1998;76:639-46. (Pubitemid 28243934)
60. Lachaise F, Martin G, Drougard C, Perl A, Vuillaume M, Wegnez M, et al. Relationship between posttranslational modification of transaldolase and catalase deficiency in UV-sensitive repair-deficient xeroderma pigmentosum fibroblasts and SV40-transformed human cells. Free Radic Biol Med 2001;30:1365-73. (Pubitemid 32522951)
61. Yu Kuang, Schomisch SJ, Chandramouli V, Lee Z. Hexokinase and glucose-6-phosphatase activity in woodchuck model of hepatitis virus-induced hepatocellular carcinoma. Comp Biochem Physiol C Toxicol Pharmacol 2006;143:225-31.
62. Ripoli M, D'Aprile A, Quarato G, Sarasin-Filipowicz M, Gouttenoire J, Scrima R, et al. Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation. J Virol 2010;84:647-60.
63. Koike K. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J Gastroenterol Hepatol 2007;22[Suppl 1]:S108-11. (Pubitemid 46849003)
64. Wu X, Zhou Y, Zhang K, Liu Q, Guo D. Isoform-specific interaction of pyruvate kinase with hepatitis C virus NS5B. FEBS Lett 2008;582:2155-60.
65. de Groof AJ, te Lindert MM, van Dommelen MM, Wu M, Willemse M, Smift AL, et al. Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype. Mol Cancer 2009;8:54.
66. Perl A, Hanczko R, Telarico T, Oaks Z, Landas S. Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase. Trends Mol Med 2011;17:395-403.
67. Waris G, Turkson J, Hassanein T, Siddiqui A. Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J Virol 2005;79:1569-80. (Pubitemid 40459104)
68. Dwarakanath BS, Singh D, Banerji AK, Sarin R, Venkataramana NK, Jalali R, et al. Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects. J Cancer Res Ther 2009;5[Suppl 1]:S21-6.
69. Henderson E, Schwartz A, Pashko L, Abou-Gharbia M, Swern D. Dehydroepiandrosterone and 16 alpha-bromo-epiandrosterone: inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes. Carcinogenesis 1981;2:683-6. (Pubitemid 11062499)
70. Boros LG, Puigjaner J, Cascante M, Lee WN, Brandes JL, Bassilian S, et al. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res 1997;57:4242-8. (Pubitemid 27413432)
71. Hagemeier SR, Barlow EA, Kleman AA, Kenney SC. The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner. J Virol 2011;85:4318-29.
72. Kutz H, Reisbach G, Schultheiss U, Kieser A. The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus. Virology 2008;371:246-56. (Pubitemid 351173227)
73. Chen SY, Lu J, Shih YC, Tsai CH. Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. J Virol 2002;76:9556-61. (Pubitemid 34919914)
74. Qadri I, Iwahashi M, Capasso JM, Hopken MW, Flores S, Schaack J, et al. Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. Biochem J 2004;378:919-28. (Pubitemid 38406869)
75. Hassan M, Ghozlan H, Abdel-Kader O. Activation of c-Jun NH2- terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth. Virology 2005;333:324-36. (Pubitemid 40250116)
76. Iwakiri D, Takada K. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation. J Immunol 2004;172:1561-6. (Pubitemid 38116801)
77. Wlodarski P, Kasprzycka M, Liu X, Marzec M, Robertson ES, Slupianek A, et al. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Cancer Res 2005;65:7800-8. (Pubitemid 41297255)
78. Cen O, Longnecker R. Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma. Mol Cancer Ther 2011;10:679-86.
79. Toh HC, Teo M, Ong KW, Lee V, Chan E, Lee AS, et al. Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumour. Lancet Oncol 2006;7:955-7. (Pubitemid 44615956)
80. Darwiche N, Sinjab A, Abou-Lteif G, Chedid MB, Hermine O, Dbaibo G, et al. Inhibition of mammalian target of rapamycin signaling by everolimus induces senescence in adult T-cell leukemia/lymphoma and apoptosis in peripheral T-cell lymphomas. Int J Cancer 2011;129:993-1004.
81. Xu RH, Pelicano H, Zhang H, Giles FJ, Keating MJ, Huang P. Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells. Leukemia 2005;19:2153-8. (Pubitemid 41741609)
82. Christians U, Gottschalk S, Miljus J, Hainz C, Benet LZ, Leibfritz D, et al. Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors. Br J Pharmacol 2004;143:388-96. (Pubitemid 39424827)